Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 6:21 AM ET


Company Overview of Genzyme Corporation

Key Executives for Genzyme Corporation

NameBoard RelationshipsTitleAge
David P. Meeker M.D.No RelationshipsChief Executive Officer and President60
Marc Esteva No RelationshipsChief Financial Officer--
John P. Butler MBA27 RelationshipsSenior Vice President and President of Personalized Genetic Health51
Scott A. Canute 56 RelationshipsExecutive Vice President and President of Manufacturing & Corporate Operations54
John G. Schulte No RelationshipsPresident of Surgical Products66
View More Key Executives

Genzyme Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Christopher A. Viehbacher 35 RelationshipsSanofi Aventis Pakistan Limited55
Henri A. Termeer 304 RelationshipsSanofi Biosurgery69
Charles Leland Cooney Ph.D. 188 RelationshipsMitra Biotech Pvt Ltd.71
Cornelius McGillicuddy III 40 RelationshipsH. Lee Moffitt Cancer Center & Research Institute74
Gail Koziara Boudreaux 45 RelationshipsNovavax, Inc.54
View All Board Members

Genzyme Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Robert J. Bertolini63 Relationships6 Executives
Compensation Committee Ph.D.Charles Leland Cooney188 Relationships6 Executives
Nominating Committee IIICornelius McGillicuddy40 Relationships5 Executives
Corporate Governance Committee IIICornelius McGillicuddy40 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$573.2K
Total Value of Options
Compensation as of Fiscal Year
Genzyme Corporation CEO Compensation
Industry Average


Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET
Pental Ltd Announces Board Appointments
November 19, 2015 9:45 PM ET
Hipolin Ltd Announces Reconstitution of Audit, Nomination and Remuneration Committee
November 06, 2015 12:30 PM ET
Church & Dwight Co. Inc. Announces Management Changes
October 29, 2015 8:38 PM ET
SCA Appoints Anna Sävinger-Åslund as its new Senior Vice President, Group Function Human Resources, Effective from November 1, 2015
October 29, 2015 6:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at